- Institut de Recerca Biomèdica de Lleida (IRB-Lleida)
Research institute
![Foto de - Institut de Recerca Biomèdica de Lleida (IRB-Lleida)](/img/noimage.png)
![Foto de QIMR Berghofer Medical Research Institute](/img/noimage_org.png)
QIMR Berghofer Medical Research Institute
Brisbane, AustraliaPublications in collaboration with researchers from QIMR Berghofer Medical Research Institute (7)
2022
-
Epithelial de-differentiation triggered by co-ordinate epigenetic inactivation of the EHF and CDX1 transcription factors drives colorectal cancer progression
Cell Death and Differentiation, Vol. 29, Núm. 11, pp. 2288-2302
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2014
-
The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like Factor 5 (KLF5)-defendent manner
Journal of Biological Chemistry, Vol. 289, Núm. 36, pp. 25306-25316
2011
-
Genome-wide association study identifies novel loci predisposing to cutaneous melanoma
Human Molecular Genetics, Vol. 20, Núm. 24, pp. 5012-5023
2009
-
Prognostic value of tyrosinase reverse transcriptase PCR analysis in melanoma sentinel lymph nodes: Long-term follow-up analysis
Clinical and Experimental Dermatology, Vol. 34, Núm. 8, pp. 863-869
2007
-
Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents
Journal of Medical Genetics, Vol. 44, Núm. 2, pp. 99-106
2006
-
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL
Cancer Research, Vol. 66, Núm. 20, pp. 9818-9828